Retractable Technologies vs Sonoma Pharmaceuticals
RVP and SNOA side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RVP and SNOA compare
Retractable Technologies is the larger company, worth 4.2 times as much as Sonoma Pharmaceuticals ($16.9M against $4.0M).
Sonoma Pharmaceuticals grew revenue faster over the last twelve months (47.0% versus −11.2% for Retractable Technologies).
Retractable Technologies keeps more of each dollar of sales as profit, with a net margin of −9.9% compared with −10.3% at Sonoma Pharmaceuticals.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RVP | SNOA |
|---|---|---|
| Size and price | ||
| Market cap | $16.9M | $4.0M |
| Share price | $0.565 | $0.834 |
| Change, 1 year | −27.4% | −75.7% |
| Change, 5 years | −93.5% | −99.2% |
| Beta (5Y) | 0.39 | 2.15 |
| Employees | 201 | 250 |
| StockData Score | ||
| Total score | 11 | 11 |
| Valuation score | 3 | 3 |
| Growth score | 1 | 3 (better) |
| Performance score | 3 (better) | 2 |
| Health score | 4 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.5× | 0.2× (better) |
| P/B | 0.2× (better) | 0.6× |
| FCF yield | – | −66.5% |
| Fair value | $3.11 | $4.70 |
| Margin of safety | 81.8% | 82.3% (better) |
| Growth | ||
| Revenue growth (TTM) | −11.2% | 47.0% (better) |
| Revenue growth, 5Y average | −14.1% | 0.95% (better) |
| Profitability | ||
| Gross margin | −1.4% | 38.9% (better) |
| Operating margin | −66.9% | −6.4% (better) |
| Net margin | −9.9% (better) | −10.3% |
| FCF margin | – | −12.1% |
| Return on equity | −4.5% (better) | −42.5% |
| Return on invested capital | −24.8% (better) | −112% |
| Financial health | ||
| Debt / equity | 0.00 | 0.02 (better) |
| Interest coverage | −278.8× | – |
| Current ratio | 4.93 (better) | 2.99 |
| Altman Z-score | 0.43 (better) | −13.69 |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | – | −99.2% |
| Shareholder yield | 0.00% (better) | −99.2% |
| Ownership | ||
| Held by institutions | 8.8% | 2.3% |
| Held by insiders | 55.7% | 11.1% |
| Insider net buying, 12 months | $0 | – |
| Short interest, % of float | 0.17% | 1.6% |
Go deeper
- RVP stock overview
- RVP income statement
- RVP valuation and score
- SNOA stock overview
- SNOA income statement
- SNOA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.